197 related articles for article (PubMed ID: 35351639)
1. The potential mechanism of Chebulae Fructus in the treatment of hepatocellular carcinoma on the basis of network pharmacology.
Jiang J; Yang Z; Hou G; Yao X; Jiang J
Ann Hepatol; 2022; 27(4):100701. PubMed ID: 35351639
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of Chebulae Fructus Immaturus promote diabetic wound healing based on network pharmacology and experimental verification.
Qiu F; Fan S; Diao Y; Liu J; Li B; Li K; Zhang W
J Ethnopharmacol; 2024 Mar; 322():117579. PubMed ID: 38104882
[TBL] [Abstract][Full Text] [Related]
3. Transcriptome profile and its partly verification of human hepatocellular carcinoma cells exposed to Yuzhizi () seed extract.
Xiaoyan F; Mingzhe LI; Long C; Chao L; Wenli LU; Zhiqiang P; Dongwei J; Peike P; Zhaoqin F; Xiaomei L
J Tradit Chin Med; 2022 Dec; 42(6):922-931. PubMed ID: 36378050
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic mechanism of
Wu Q; He M; Wang J; Tong T; Yang D; Tang H
Front Vet Sci; 2023; 10():1123449. PubMed ID: 37275616
[TBL] [Abstract][Full Text] [Related]
5. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
6. A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma.
Zhou X; Tan F; Zhang S; Wang A; Zhang T
Curr Pharm Des; 2024; 30(5):377-405. PubMed ID: 38310567
[TBL] [Abstract][Full Text] [Related]
7. Revealing the potential mechanism of Astragalus membranaceus improving prognosis of hepatocellular carcinoma by combining transcriptomics and network pharmacology.
Liu Z; Ma H; Lai Z
BMC Complement Med Ther; 2021 Oct; 21(1):263. PubMed ID: 34663301
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
[No Abstract] [Full Text] [Related]
9. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
[TBL] [Abstract][Full Text] [Related]
10. Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (
Yu Y; Ding S; Xu X; Yan D; Fan Y; Ruan B; Zhang X; Zheng L; Jie W; Zheng S
Drug Des Devel Ther; 2023; 17():659-673. PubMed ID: 36883114
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of Glycitein in the Treatment of Colon Cancer Based on Network Pharmacology and Molecular Docking.
Xiang T; Jin W
Lifestyle Genom; 2023; 16(1):1-10. PubMed ID: 36183698
[TBL] [Abstract][Full Text] [Related]
12. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis.
Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z
World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149
[TBL] [Abstract][Full Text] [Related]
13. Network Pharmacology-Based Strategy to Investigate the Mechanisms of Lenvatinib in the Treatment of Hepatocellular Carcinoma.
Liu P; Han B; Zhang Y; Wang X
Comput Intell Neurosci; 2022; 2022():7102500. PubMed ID: 35720901
[TBL] [Abstract][Full Text] [Related]
14. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
15. Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis.
Han T; Liu Y; Chen Y; Chen T; Li Y; Li Q; Zhao M
Oxid Med Cell Longev; 2022; 2022():2663758. PubMed ID: 36193082
[TBL] [Abstract][Full Text] [Related]
16. Comparison of pharmacokinetic profiles of Terminalia phenolics after intragastric administration of the aqueous extracts of the fruit of Terminalia chebula and a Mongolian compound medicine-Gurigumu-7.
Gao J; Ajala OS; Wang CY; Xu HY; Yao JH; Zhang HP; Jukov A; Ma CM
J Ethnopharmacol; 2016 Jun; 185():300-9. PubMed ID: 26972503
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis of the molecular signature of target genes involved in the antitumor effects of cantharidin on hepatocellular carcinoma.
Yan J; Gao YM; Deng XL; Wang HS; Shi GT
BMC Cancer; 2023 Nov; 23(1):1161. PubMed ID: 38017425
[TBL] [Abstract][Full Text] [Related]
18. Network Pharmacology-Based Approach Combined with Bioinformatic Analytics to Elucidate the Potential of Curcumol against Hepatocellular Carcinoma.
Huang X; Rehman HM; Szöllősi AG; Zhou S
Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456457
[TBL] [Abstract][Full Text] [Related]
19. Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma.
Jiang X; Zhang W; Li L; Xie S
Pathol Oncol Res; 2021; 27():1609985. PubMed ID: 34737677
[TBL] [Abstract][Full Text] [Related]
20. A systematic approach to decode the mechanism of Cornus in the treatment of hepatocellular carcinoma (HCC).
Shen HY; Li XQ; Fan WQ; Wang YW; Huang F; Wu JQ; Zhang W; Feng XS; Chao X
Eur J Pharmacol; 2021 Oct; 909():174405. PubMed ID: 34384755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]